Format

Send to

Choose Destination
Rev Med Suisse. 2018 Feb 14;14(594):384-389.

[Kawasaki disease: an update].

[Article in French; Abstract available in French from the publisher]

Author information

1
Unité de cardiologie pédiatrique, Service de pédiatrie, Département femme-mère-enfant, CHUV, 1011 Lausanne.
2
Unité d'immuno-allergologie et rhumatologie pédiatrique, Service de pédiatrie, Département femme-mère-enfant, CHUV, 1011 Lausanne.
3
Département de pédiatrie, Ospedale Regionale di Bellinzona e Valli, 6500 Bellinzona.

Abstract

in English, French

The cause of Kawasaki disease (KD) is still unknown, but an infectious origin and genetic susceptibility have been suggested. The American Heart Association has changed the guidelines for diagnosis and treatment of KD in 2017. One goal is to better identify patients most at risk, particularly young children with « incomplete » KD. In case of intravenous immunoglobulin resistance, alternative treatments to the traditional use of corticosteroids, such as TNF-alpha inhibitors have been proposed. For all patients with coronary aneurisms, regular assessment of myocardial perfusion is recommended, either with stress echocardiography, MRI, scintigraphy or PET-scan.

PMID:
29461753

Conflict of interest statement

Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.

Supplemental Content

Loading ...
Support Center